Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
Access Status
Authors
Date
2018Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Remarks
Please see the attached document for a complete list of authors
Collection
Abstract
© 2018, The Author(s). The total number of acquired melanocytic nevi on the skin is strongly correlated with melanoma risk. Here we report a meta-analysis of 11 nevus GWAS from Australia, Netherlands, UK, and USA comprising 52,506 individuals. We confirm known loci including MTAP, PLA2G6, and IRF4, and detect novel SNPs in KITLG and a region of 9q32. In a bivariate analysis combining the nevus results with a recent melanoma GWAS meta-analysis (12,874 cases, 23,203 controls), SNPs near GPRC5A, CYP1B1, PPARGC1B, HDAC4, FAM208B, DOCK8, and SYNE2 reached global significance, and other loci, including MIR146A and OBFC1, reached a suggestive level. Overall, we conclude that most nevus genes affect melanoma risk (KITLG an exception), while many melanoma risk loci do not alter nevus count. For example, variants in TERC and OBFC1 affect both traits, but other telomere length maintenance genes seem to affect melanoma risk only. Our findings implicate multiple pathways in nevogenesis.
Related items
Showing items related by title, author, creator and subject.
-
Cadby, G.; Ward, S.; Cole, J.; Moses, Eric; Millward, M.; Palmer, L. (2014)Background: Breslow thickness is the most important predictor of survival in localized malignant melanoma. A number of melanoma risk factors have been shown to be associated with Breslow thickness; however, the role of ...
-
Law, M.; Bishop, D.; Lee, J.; Brossard, M.; Martin, N.; Moses, Eric; Song, F.; Barrett, J.; Kumar, R.; Easton, D.; Pharoah, P.; Swerdlow, A.; Kypreou, K.; Taylor, J.; Harland, M.; Randerson-Moor, J.; Akslen, L.; Andresen, P.; Avril, M.; Azizi, E.; Scarrà, G.; Brown, K.; Debniak, T.; Duffy, D.; Elder, D.; Fang, S.; Friedman, E.; Galan, P.; Ghiorzo, P.; Gillanders, E.; Goldstein, A.; Gruis, N.; Hansson, J.; Helsing, P.; Hocevar, M.; Höiom, V.; Ingvar, C.; Kanetsky, P.; Chen, W.; Landi, M.; Lang, J.; Lathrop, G.; Lubinski, J.; MacKie, R.; Mann, G.; Molven, A.; Montgomery, G.; Novakovic, S.; Olsson, H.; Puig, S.; Puig-Butille, J.; Qureshi, A.; Radford-Smith, G.; Van Der Stoep, N.; Van Doorn, R.; Whiteman, D.; Craig, J.; Schadendorf, D.; Simms, L.; Burdon, K.; Nyholt, D.; Pooley, K.; Orr, N.; Stratigos, A.; Cust, A.; Ward, S.; Hayward, N.; Han, J.; Schulze, H.; Dunning, A.; Bishop, J.; Demenais, F.; Amos, C.; MacGregor, S.; Iles, M. (2015)Thirteen common susceptibility loci have been reproducibly associated with cutaneous malignant melanoma (CMM). We report the results of an international 2-stage meta-analysis of CMM genome-wide association studies (GWAS). ...
-
Dye, Danielle; Medic, S.; Ziman, M.; Coombe, Deirdre (2013)The majority of patients diagnosed with melanoma present with thin lesions and generally these patients have a good prognosis. However, 5% of patients with early melanoma (<1 mm thick) will have recurrence and die within ...